Bedaquiline in the treatment regimen of multidrugresistant tuberculosis (clinical observation)
Current trials are underway to design chemotherapy regimens that include bedaquiline to treat children with rifampicin and isoniazid resistant mycobacterium tuberculosis. This clinical observation is interesting from the viewpoint of experience of the potential effective and safe use of the new anti...
Main Authors: | V. A. Aksenova, N. I. Klevno, A. D. Pakhlavonova, A. V. Kazakov, E. A. Sokolskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5881 |
Similar Items
-
Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
by: Shereen Katrak, et al.
Published: (2021-05-01) -
Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients
by: Jingtao Gao, et al.
Published: (2020-11-01) -
Bedaquiline: Current status and future perspectives
by: Saeed Khoshnood, et al.
Published: (2021-06-01) -
Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety
by: Jing-Tao Gao, et al.
Published: (2021-03-01) -
The efficacy and safety of bedaquiline in multi-drug resistant tuberculosis
by: Lu, Edgar
Published: (2018)